361 related articles for article (PubMed ID: 15927518)
1. Insulin-like growth factor-I inhibits dexamethasone-induced proteolysis in cultured L6 myotubes through PI3K/Akt/GSK-3beta and PI3K/Akt/mTOR-dependent mechanisms.
Li BG; Hasselgren PO; Fang CH
Int J Biochem Cell Biol; 2005 Oct; 37(10):2207-16. PubMed ID: 15927518
[TBL] [Abstract][Full Text] [Related]
2. Protein breakdown in muscle from burned rats is blocked by insulin-like growth factor i and glycogen synthase kinase-3beta inhibitors.
Fang CH; Li BG; James JH; King JK; Evenson AR; Warden GD; Hasselgren PO
Endocrinology; 2005 Jul; 146(7):3141-9. PubMed ID: 15802492
[TBL] [Abstract][Full Text] [Related]
3. GSK-3beta inhibitors reduce protein degradation in muscles from septic rats and in dexamethasone-treated myotubes.
Evenson AR; Fareed MU; Menconi MJ; Mitchell JC; Hasselgren PO
Int J Biochem Cell Biol; 2005 Oct; 37(10):2226-38. PubMed ID: 16051512
[TBL] [Abstract][Full Text] [Related]
4. Insulin and IGF-I stimulate the formation of the eukaryotic initiation factor 4F complex and protein synthesis in C2C12 myotubes independent of availability of external amino acids.
Shen WH; Boyle DW; Wisniowski P; Bade A; Liechty EA
J Endocrinol; 2005 May; 185(2):275-89. PubMed ID: 15845920
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of PI-3 kinase/Akt/mTOR, but not calcineurin signaling, reverses insulin-like growth factor I-induced protection against glucose toxicity in cardiomyocyte contractile function.
Li SY; Fang CX; Aberle NS; Ren BH; Ceylan-Isik AF; Ren J
J Endocrinol; 2005 Sep; 186(3):491-503. PubMed ID: 16135669
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor-I blocks dexamethasone-induced protein degradation in cultured myotubes by inhibiting multiple proteolytic pathways: 2002 ABA paper.
Li BG; Hasselgren PO; Fang CH; Warden GD
J Burn Care Rehabil; 2004; 25(1):112-8. PubMed ID: 14726748
[TBL] [Abstract][Full Text] [Related]
7. Glycogen synthase kinase-3β is required for the induction of skeletal muscle atrophy.
Verhees KJ; Schols AM; Kelders MC; Op den Kamp CM; van der Velden JL; Langen RC
Am J Physiol Cell Physiol; 2011 Nov; 301(5):C995-C1007. PubMed ID: 21832246
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor I-mediated protection from rapamycin-induced apoptosis is independent of Ras-Erk1-Erk2 and phosphatidylinositol 3'-kinase-Akt signaling pathways.
Thimmaiah KN; Easton J; Huang S; Veverka KA; Germain GS; Harwood FC; Houghton PJ
Cancer Res; 2003 Jan; 63(2):364-74. PubMed ID: 12543789
[TBL] [Abstract][Full Text] [Related]
9. Homologous posttranscriptional regulation of insulin-like growth factor-I receptor level via glycogen synthase kinase-3beta and mammalian target of rapamycin in adrenal chromaffin cells: effect on tau phosphorylation.
Nemoto T; Satoh S; Maruta T; Kanai T; Yoshikawa N; Miyazaki S; Yanagita T; Wada A
Neuropharmacology; 2010 Jun; 58(7):1097-108. PubMed ID: 20144629
[TBL] [Abstract][Full Text] [Related]
10. Des-acyl ghrelin exhibits pro-anabolic and anti-catabolic effects on C2C12 myotubes exposed to cytokines and reduces burn-induced muscle proteolysis in rats.
Sheriff S; Kadeer N; Joshi R; Friend LA; James JH; Balasubramaniam A
Mol Cell Endocrinol; 2012 Apr; 351(2):286-95. PubMed ID: 22266196
[TBL] [Abstract][Full Text] [Related]
11. Regulation of REDD1 by insulin-like growth factor-I in skeletal muscle and myotubes.
Frost RA; Huber D; Pruznak A; Lang CH
J Cell Biochem; 2009 Dec; 108(5):1192-202. PubMed ID: 19795384
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of glycogen synthase kinase 3beta activity regulates proliferation of cultured cerebellar granule cells.
Cui H; Meng Y; Bulleit RF
Brain Res Dev Brain Res; 1998 Dec; 111(2):177-88. PubMed ID: 9838099
[TBL] [Abstract][Full Text] [Related]
13. Muscle-specific overexpression of the type 1 IGF receptor results in myoblast-independent muscle hypertrophy via PI3K, and not calcineurin, signaling.
Quinn LS; Anderson BG; Plymate SR
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1538-51. PubMed ID: 17940216
[TBL] [Abstract][Full Text] [Related]
14. Glycogen synthase kinase-3beta is involved in the process of myocardial hypertrophy stimulated by insulin-like growth factor-1.
Seimi SK; Seinosuke K; Tsuyoshi S; Tomomi U; Tetsuaki H; Miki K; Ryuji T; Kenji I; Mitsuhiro Y
Circ J; 2004 Mar; 68(3):247-53. PubMed ID: 14993781
[TBL] [Abstract][Full Text] [Related]
15. AMP-activated protein kinase enhances the expression of muscle-specific ubiquitin ligases despite its activation of IGF-1/Akt signaling in C2C12 myotubes.
Tong JF; Yan X; Zhu MJ; Du M
J Cell Biochem; 2009 Oct; 108(2):458-68. PubMed ID: 19639604
[TBL] [Abstract][Full Text] [Related]
16. Insulin like growth factor-1 prevents 1-mentyl-4-phenylphyridinium-induced apoptosis in PC12 cells through activation of glycogen synthase kinase-3beta.
Sun X; Huang L; Zhang M; Sun S; Wu Y
Toxicology; 2010 Apr; 271(1-2):5-12. PubMed ID: 20064577
[TBL] [Abstract][Full Text] [Related]
17. Involvement of PI3K/Akt/GSK-3β and mTOR in the antidepressant-like effect of atorvastatin in mice.
Ludka FK; Constantino LC; Dal-Cim T; Binder LB; Zomkowski A; Rodrigues AL; Tasca CI
J Psychiatr Res; 2016 Nov; 82():50-7. PubMed ID: 27468164
[TBL] [Abstract][Full Text] [Related]
18. IGF-I activates the mouse type IIb myosin heavy chain gene.
Shanely RA; Zwetsloot KA; Childs TE; Lees SJ; Tsika RW; Booth FW
Am J Physiol Cell Physiol; 2009 Oct; 297(4):C1019-27. PubMed ID: 19657059
[TBL] [Abstract][Full Text] [Related]
19. GSK-3beta negatively regulates skeletal myotube hypertrophy.
Vyas DR; Spangenburg EE; Abraha TW; Childs TE; Booth FW
Am J Physiol Cell Physiol; 2002 Aug; 283(2):C545-51. PubMed ID: 12107064
[TBL] [Abstract][Full Text] [Related]
20. In vitro mechanisms involved in the regulation of cell survival by lithium chloride and IGF-1 in human hormone-dependent breast cancer cells (MCF-7).
Suganthi M; Sangeetha G; Benson CS; Babu SD; Sathyavathy A; Ramadoss S; Ravi Sankar B
Toxicol Lett; 2012 Oct; 214(2):182-91. PubMed ID: 22964364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
